Drawing for REMOBBA

USPTO serial 79098981

REMOBBA

Reviewed by CopyMark Law Group

Reg. 4075902Status 404
Filing date
Status date
Registration date
Dec 27, 2011
Examiner
FATHY, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REMOBBA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, medicines for treating hemangiomaSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 5, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
May 17, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Apr 23, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 23, 2019INPCINVALIDATION PROCESSED
Apr 3, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 3, 2018C71TCANCELLED SECTION 71
Sep 21, 2012GPNXNOTIFICATION PROCESSED BY IB
Jun 4, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 4, 2012FIMPFINAL DISPOSITION PROCESSED
Jan 26, 2012GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 27, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 18, 2011GPNXNOTIFICATION PROCESSED BY IB
Oct 11, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 21, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 21, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 21, 2011NPUBNOTICE OF PUBLICATION
Sep 8, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2011DOCKASSIGNED TO EXAMINER
Jul 23, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Jul 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2011LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 14, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance